Eversept Partners’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Hold |
100,752
| – | – | 0.02% | 67 |
|
|
2025
Q1 | $188K | Buy |
+100,752
| New | +$188K | 0.02% | 55 |
|
|
2024
Q4 | – | Sell |
-99,313
| Closed | -$375K | – | 63 |
|
|
2024
Q3 | $375K | Hold |
99,313
| – | – | 0.03% | 65 |
|
|
2024
Q2 | $396K | Sell |
99,313
-25,276
| -20% | -$101K | 0.03% | 71 |
|
|
2024
Q1 | $369K | Hold |
124,589
| – | – | 0.02% | 68 |
|
|
2023
Q4 | $623K | Hold |
124,589
| – | – | 0.05% | 55 |
|
|
2023
Q3 | $355K | Hold |
124,589
| – | – | 0.03% | 61 |
|
|
2023
Q2 | $368K | Hold |
124,589
| – | – | 0.03% | 64 |
|
|
2023
Q1 | $292K | Hold |
124,589
| – | – | 0.02% | 58 |
|
|
2022
Q4 | $254K | Hold |
124,589
| – | – | 0.02% | 59 |
|
|
2022
Q3 | $394K | Hold |
124,589
| – | – | 0.03% | 54 |
|
|
2022
Q2 | $450K | Hold |
124,589
| – | – | 0.03% | 61 |
|
|
2022
Q1 | $498K | Sell |
124,589
-28,791
| -19% | -$115K | 0.04% | 66 |
|
|
2021
Q4 | $759K | Sell |
153,380
-68,369
| -31% | -$338K | 0.05% | 78 |
|
|
2021
Q3 | $1.49M | Buy |
+221,749
| New | +$1.49M | 0.1% | 72 |
|